homocysteine and Deficiency, Protein S

homocysteine has been researched along with Deficiency, Protein S in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's9 (75.00)18.2507
2000's2 (16.67)29.6817
2010's1 (8.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ashraf, MZ; Behari, M; Chatterjee, T; Choudhry, VP; Gupta, N; Saxena, R1
Darioli, R; Mathez, Ch; Trueb, L; Waeber, G1
Fields, MC; Levine, SR1
de Vries, JI; Dekker, GA; Doelitzsch, PM; Huijgens, PC; Jakobs, C; van Geijn, HP; von Blomberg, BM1
Clark, WM; Coull, BM1
Blom, HJ; Bos, GM; Briet, E; den Heijer, M; Koster, T; Reitsma, PH; Rosendaal, FR; Vandenbroucke, JP1
Dekker, GA; van Geijn, HP1
Blomberg, BM; de Vries, JI; Dekker, GA; Huijgens, PC; Jakobs, C; van Geijn, HP1
Bernardi, F; Coccheri, S; Ferraresi, P; Grauso, F; Grossi, G; Legnani, C; Marchetti, G; Palareti, G; Piazzi, S; Sassi, S1
Francis, JL1
Arroliga, AC; Marelich, GP; Matthay, RA; Murin, S1
Sacher, RA1

Reviews

5 review(s) available for homocysteine and Deficiency, Protein S

ArticleYear
Abnormalities of hemostasis in ischemic stroke.
    The Medical clinics of North America, 1993, Volume: 77, Issue:1

    Topics: Antithrombin III Deficiency; Cerebrovascular Disorders; Hemoglobin SC Disease; Hemostasis; Homocysteine; Humans; Myeloproliferative Disorders; Protein C Deficiency; Protein S Deficiency

1993
Endothelial dysfunction in preeclampsia. Part II: Reducing the adverse consequences of endothelial cell dysfunction in preeclampsia; therapeutic perspectives.
    Journal of perinatal medicine, 1996, Volume: 24, Issue:2

    Topics: Antibodies, Anticardiolipin; Aspirin; Endothelium, Vascular; Female; Fibrinolytic Agents; Homocysteine; Humans; Platelet Aggregation Inhibitors; Pre-Eclampsia; Pregnancy; Protein S Deficiency

1996
Laboratory investigation of hypercoagulability.
    Seminars in thrombosis and hemostasis, 1998, Volume: 24, Issue:2

    Topics: Afibrinogenemia; Antiphospholipid Syndrome; Antithrombins; Blood Coagulation Tests; Factor V; Fibrinolysis; Homocysteine; Humans; Lipoproteins; Lupus Coagulation Inhibitor; Monocytes; Platelet Activation; Protein C; Protein S; Protein S Deficiency; Prothrombin; Thrombomodulin; Thrombophilia; Thromboplastin

1998
Hereditary thrombophilia and venous thromboembolism.
    American journal of respiratory and critical care medicine, 1998, Volume: 158, Issue:5 Pt 1

    Topics: Antithrombin III Deficiency; Factor V; Genetic Predisposition to Disease; Homocysteine; Humans; Mutation; Prevalence; Protein C; Protein C Deficiency; Protein S Deficiency; Prothrombin; Thrombophilia; Venous Thrombosis

1998
Thrombophilia: a genetic predisposition to thrombosis.
    Transactions of the American Clinical and Climatological Association, 1999, Volume: 110

    Topics: Activated Protein C Resistance; Antithrombins; Fibrinolysis; Homocysteine; Humans; Mutation; Protein C Deficiency; Protein S Deficiency; Prothrombin; Risk Factors; Thromboembolism; Thrombophilia; Thrombosis

1999

Other Studies

7 other study(ies) available for homocysteine and Deficiency, Protein S

ArticleYear
Prediction of ischemic stroke in young Indians: is thrombophilia profiling a way out?
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2013, Volume: 24, Issue:4

    Topics: Adolescent; Adult; Antithrombin III; Brain Ischemia; Case-Control Studies; Female; Homocysteine; Humans; Hyperhomocysteinemia; India; Lupus Coagulation Inhibitor; Male; Methylenetetrahydrofolate Reductase (NADPH2); Polymorphism, Genetic; Prognosis; Protein C; Protein C Deficiency; Protein S; Protein S Deficiency; Prothrombin; Stroke; Thrombophilia

2013
[Homocystein and cardiovascular risk: is dosage useful?].
    Praxis, 2004, Dec-08, Volume: 93, Issue:50

    Topics: Adult; Coronary Artery Disease; DNA Mutational Analysis; Genetic Carrier Screening; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Myocardial Infarction; Protein S Deficiency; Prothrombin; Recurrence; Risk Factors; Thrombophilia

2004
Thrombophilias and stroke: diagnosis, treatment, and prognosis.
    Journal of thrombosis and thrombolysis, 2005, Volume: 20, Issue:2

    Topics: Anticoagulants; Cystathionine beta-Synthase; Factor V; Genetic Predisposition to Disease; Genetic Testing; Homocysteine; Humans; Hyperhomocysteinemia; Ischemic Attack, Transient; Methylenetetrahydrofolate Reductase (NADPH2); Platelet Activation; Platelet Aggregation; Polymorphism, Genetic; Prognosis; Protein S Deficiency; Prothrombin; Secondary Prevention; Stroke; Thrombophilia; Warfarin

2005
Underlying disorders associated with severe early-onset preeclampsia.
    American journal of obstetrics and gynecology, 1995, Volume: 173, Issue:4

    Topics: Antibodies, Anticardiolipin; Antithrombin III Deficiency; Female; Homocysteine; Humans; Hypertension; Pre-Eclampsia; Pregnancy; Protein C; Protein S Deficiency; Thrombosis

1995
Hyperhomocysteinemia as a risk factor for deep-vein thrombosis.
    The New England journal of medicine, 1996, Mar-21, Volume: 334, Issue:12

    Topics: Adolescent; Adult; Age Factors; Aged; Case-Control Studies; Female; Homocysteine; Homocystine; Humans; Male; Middle Aged; Odds Ratio; Protein C Deficiency; Protein S Deficiency; Risk Factors; Sex Factors; Thrombophlebitis

1996
Hyperhomocysteinaemia and protein S deficiency in complicated pregnancies.
    British journal of obstetrics and gynaecology, 1997, Volume: 104, Issue:11

    Topics: Abruptio Placentae; Antibodies, Anticardiolipin; Blood Coagulation Disorders; Female; Fetal Death; Gestational Age; Homocysteine; Humans; Infant, Small for Gestational Age; Pregnancy; Pregnancy Complications, Hematologic; Protein S Deficiency; Risk Factors

1997
Hyperhomocyst(e)inemia and a common methylenetetrahydrofolate reductase mutation (Ala223Val MTHFR) in patients with inherited thrombophilic coagulation defects.
    Arteriosclerosis, thrombosis, and vascular biology, 1997, Volume: 17, Issue:11

    Topics: Adult; Aged; Antithrombin III; Antithrombin III Deficiency; Disease Susceptibility; Enzyme Activation; Factor V; Gene Frequency; Genotype; Homocysteine; Homocystine; Humans; Italy; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Point Mutation; Protein C; Protein S Deficiency; Risk Factors; Thrombophilia

1997